Symbols / TVGN $4.46 -0.45% Tevogen Bio Holdings Inc.

Healthcare • Biotechnology • United States • NGM
TVGN Chart
About

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in Phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 18.06M
Enterprise Value 34.32M Income -26.83M Sales —
Book/sh -2.12 Cash/sh 0.13 Dividend Yield —
Payout 0.00% Employees 18 IPO —
P/E — Forward P/E — PEG —
P/S — P/B -2.11 P/C —
EV/EBITDA -1.32 EV/Sales — Quick Ratio 0.10
Current Ratio 0.22 Debt/Eq — LT Debt/Eq —
EPS (ttm) -8.08 EPS next Y — EPS Growth —
Revenue Growth — Earnings 2026-05-15 ROA -4.17%
ROE — ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 4.05M
Shs Float 969.47K Short Float 7.09% Short Ratio 2.30
Short Interest — 52W High 75.50 52W Low 4.13
Beta -0.30 Avg Volume 27.82K Volume 18.73K
Target Price — Recom None Prev Close $4.48
Price $4.46 Change -0.45%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$4.49
Latest analyst target
3. DCF / Fair value
$-7.89
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.49
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-04 down D. Boral Capital Buy → Hold —
2026-03-03 main D. Boral Capital Buy → Buy $2
2025-11-20 main D. Boral Capital Buy → Buy $5
2025-09-04 main D. Boral Capital Buy → Buy $10
2025-08-18 main D. Boral Capital Buy → Buy $10
2025-08-06 main D. Boral Capital Buy → Buy $10
2025-08-04 main D. Boral Capital Buy → Buy $10
2025-06-18 main D. Boral Capital Buy → Buy $10
2025-06-10 main D. Boral Capital Buy → Buy $10
2025-05-27 main D. Boral Capital Buy → Buy $10
2025-05-12 main D. Boral Capital Buy → Buy $10
2025-04-29 main D. Boral Capital Buy → Buy $10
2025-04-21 main D. Boral Capital Buy → Buy $10
2025-03-11 main D. Boral Capital Buy → Buy $10
2025-03-04 init D. Boral Capital — → Buy $10
News
RSS: Latest TVGN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-12-18 SAADI RYAN H Chief Executive Officer — 50,000 $0.00 $0
2025-12-11 SAADI RYAN H Chief Executive Officer — 460,000 $0.00 $0
2025-12-11 DESAI KIRTI Chief Financial Officer — 300,000 $0.00 $0
2025-08-15 SAADI RYAN H Chief Executive Officer — 20,000 $0.00 $0
2025-06-27 KHAN SADIQ Officer — 200,000 $0.00 $0
2025-06-27 SAADI RYAN H Chief Executive Officer — 8,000,000 $0.00 $0
2025-06-27 DESAI KIRTI Chief Financial Officer — 750,000 $0.00 $0
2025-06-27 FLOMENBERG NEAL Officer — 300,000 $0.00 $0
2025-06-09 SAADI RYAN H Chief Executive Officer — 1,438,206 $1.23 $1,768,993
2025-03-12 FLOMENBERG NEAL Officer — 232,968 $1.09 $253,935
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
26.14
-51.20%
53.56
+505.73%
8.84
+827.83%
0.95
Research And Development
11.11
-64.19%
31.03
+604.74%
4.40
-23.74%
5.77
Selling General And Administration
15.03
-33.30%
22.53
+407.52%
4.44
+365.80%
0.95
General And Administrative Expense
15.03
-33.30%
22.53
+407.52%
4.44
+365.80%
0.95
Salaries And Wages
10.88
-29.72%
15.48
+1312.85%
1.10
-81.12%
5.80
Other Gand A
4.15
-41.15%
7.05
+110.94%
3.34
+250.86%
0.95
Total Expenses
26.14
-51.20%
53.56
+505.73%
8.84
+827.83%
0.95
Operating Income
-26.14
+51.20%
-53.56
-505.73%
-8.84
-827.83%
-0.95
Total Operating Income As Reported
-26.14
+51.20%
-53.56
-505.73%
-8.84
+35.57%
-13.72
EBITDA
-25.57
-94.60%
-13.14
+77.69%
-58.89
-1435.94%
4.41
Normalized EBITDA
-25.63
-446.25%
-4.69
+92.03%
-58.89
-6079.21%
-0.95
Reconciled Depreciation
0.51
+26.17%
0.40
+6.67%
0.38
+63.92%
0.23
EBIT
-26.08
-92.57%
-13.54
+77.15%
-59.27
-1444.52%
4.41
Total Unusual Items
0.06
+100.72%
-8.45
0.00
-100.00%
5.36
Total Unusual Items Excluding Goodwill
0.06
+100.72%
-8.45
0.00
-100.00%
5.36
Special Income Charges
0.00
+100.00%
-7.50
0.00
0.00
Restructuring And Mergern Acquisition
0.00
-100.00%
7.50
0.00
—
Write Off
—
—
0.25
0.00
Net Income
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Pretax Income
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Net Non Operating Interest Income Expense
-0.20
-6.29%
-0.18
+84.74%
-1.21
0.00
Interest Expense Non Operating
0.20
+6.29%
0.18
-84.74%
1.21
0.00
Net Interest Income
-0.20
-6.29%
-0.18
+84.74%
-1.21
0.00
Interest Expense
0.20
+6.29%
0.18
-84.74%
1.21
0.00
Other Income Expense
0.06
-99.85%
40.02
+179.36%
-50.43
-1040.57%
5.36
Other Non Operating Income Expenses
—
48.47
+196.11%
-50.43
-582.86%
-7.38
Gain On Sale Of Security
0.06
+106.40%
-0.95
-134.95%
2.71
-49.40%
5.36
Tax Rate For Calcs
0.00
0.00
0.00
-100.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
-100.00%
1.13
Net Income Including Noncontrolling Interests
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Net Income From Continuing Operation Net Minority Interest
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Net Income From Continuing And Discontinued Operation
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Net Income Continuous Operations
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Normalized Income
-26.34
-398.80%
-5.28
+91.27%
-60.48
-35094.56%
0.17
Net Income Common Stockholders
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Diluted EPS
-8.08
-130.86%
-3.50
+81.70%
-19.12
-1141.19%
1.84
Basic EPS
-8.08
-130.86%
-3.50
+81.70%
-19.12
-1141.19%
1.84
Basic Average Shares
3.32
+13.17%
2.93
-11.33%
3.31
+37.85%
2.40
Diluted Average Shares
3.32
+13.17%
2.93
-11.33%
3.31
+37.85%
2.40
Diluted NI Availto Com Stockholders
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
4.38
+26.61%
3.46
-37.12%
5.51
-98.46%
357.14
Current Assets
1.54
-34.78%
2.36
+37.02%
1.72
+528.01%
0.27
Cash Cash Equivalents And Short Term Investments
0.55
-56.95%
1.28
+21.91%
1.05
+714.64%
0.13
Cash And Cash Equivalents
0.55
-56.95%
1.28
+21.91%
1.05
+714.64%
0.13
Cash Financial
0.55
-56.95%
1.28
+21.91%
1.05
+714.64%
0.13
Receivables
0.16
+0.00%
0.16
0.00
0.00
Other Current Assets
0.83
-9.85%
0.92
+37.06%
0.67
+361.93%
0.15
Total Non Current Assets
2.84
+158.29%
1.10
-70.90%
3.78
-98.94%
356.86
Net PPE
1.59
+203.62%
0.52
-43.47%
0.93
-28.95%
1.31
Gross PPE
2.01
+111.34%
0.95
-20.26%
1.19
-15.29%
1.41
Accumulated Depreciation
-0.41
+2.54%
-0.43
-61.65%
-0.26
-163.60%
-0.10
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
0.46
+0.00%
0.46
+0.00%
0.46
+0.00%
0.46
Other Properties
1.42
+522.99%
0.23
-51.37%
0.47
-31.40%
0.68
Leases
0.13
-52.02%
0.26
+0.00%
0.26
+0.00%
0.26
Non Current Deferred Assets
0.18
0.00
-100.00%
2.58
—
Other Non Current Assets
1.07
+85.10%
0.58
+112.38%
0.27
-99.92%
356.86
Total Liabilities Net Minority Interest
12.62
+24.49%
10.14
-89.86%
99.93
+563.68%
15.06
Current Liabilities
7.07
-21.83%
9.04
-89.42%
85.48
+24291.09%
0.35
Payables And Accrued Expenses
4.76
-29.60%
6.76
+53.81%
4.39
+1154.00%
0.35
Payables
3.59
-34.13%
5.45
+59.44%
3.42
+875.41%
0.35
Accounts Payable
3.34
-35.77%
5.20
+52.13%
3.42
+1524.29%
0.21
Current Accrued Expenses
1.17
-10.74%
1.31
+34.09%
0.98
+68.69%
0.58
Current Debt And Capital Lease Obligation
1.98
+5.25%
1.88
-97.68%
80.96
+29002.33%
0.28
Current Debt
1.65
+0.00%
1.65
-97.95%
80.71
—
Other Current Borrowings
—
—
80.71
—
Current Capital Lease Obligation
0.33
+43.08%
0.23
-9.36%
0.25
-9.16%
0.28
Other Current Liabilities
0.33
-17.89%
0.40
+235.61%
0.12
-49.43%
0.24
Total Non Current Liabilities Net Minority Interest
5.55
+407.72%
1.09
-92.44%
14.45
-1.72%
14.71
Long Term Debt And Capital Lease Obligation
5.52
+449.09%
1.01
-93.04%
14.45
-63.62%
39.73
Long Term Debt
4.40
+340.00%
1.00
-92.97%
14.22
-63.81%
39.30
Long Term Capital Lease Obligation
1.12
+19271.12%
0.01
-97.53%
0.23
-45.73%
0.43
Non Current Deferred Liabilities
—
—
14.70
+0.00%
14.70
Stockholders Equity
-8.23
-23.39%
-6.67
+92.93%
-94.43
-127.60%
342.08
Common Stock Equity
-17.03
-10.09%
-15.47
+83.61%
-94.43
-127.60%
342.08
Capital Stock
8.80
+0.00%
8.80
+73236.22%
0.01
-100.00%
356.87
Common Stock
0.00
+12.92%
0.00
-97.03%
0.01
-100.00%
356.87
Preferred Stock
8.80
+0.00%
8.80
0.00
0.00
Share Issued
4.02
+12.95%
3.56
+7.60%
3.31
+4.62%
3.16
Ordinary Shares Number
4.02
+12.95%
3.56
+7.60%
3.31
+4.62%
3.16
Additional Paid In Capital
122.63
+25.24%
97.91
+1776.82%
5.22
+0.97%
5.17
Retained Earnings
-139.66
-23.17%
-113.39
-13.77%
-99.66
-574.06%
-14.78
Total Equity Gross Minority Interest
-8.23
-23.39%
-6.67
+92.93%
-94.43
-127.60%
342.08
Total Capitalization
-3.83
+32.42%
-5.67
+92.93%
-80.21
-123.45%
342.08
Working Capital
-5.53
+17.26%
-6.68
+92.02%
-83.76
-109964.08%
-0.08
Invested Capital
-10.98
+14.34%
-12.82
-2648.78%
0.50
-99.85%
342.08
Total Debt
7.50
+159.94%
2.89
-96.98%
95.42
+138.50%
40.01
Net Debt
5.50
+301.95%
1.37
-98.54%
93.88
+177.65%
33.81
Capital Lease Obligations
1.45
+517.60%
0.23
-51.83%
0.49
-31.42%
0.71
Net Tangible Assets
-8.23
-23.39%
-6.67
+92.93%
-94.43
-127.60%
342.08
Tangible Book Value
-17.03
-10.09%
-15.47
+83.61%
-94.43
-127.60%
342.08
Current Notes Payable
1.65
+0.00%
1.65
0.00
—
Derivative Product Liabilities
0.03
-69.63%
0.09
0.00
-100.00%
0.01
Duefrom Related Parties Current
0.16
+0.00%
0.16
0.00
0.00
Dueto Related Parties Current
0.25
+0.00%
0.25
0.00
-100.00%
0.14
Preferred Stock Equity
8.80
+0.00%
8.80
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-12.33
-2.75%
-12.00
-46.84%
-8.17
-3693.55%
-0.22
Cash Flow From Continuing Operating Activities
-12.33
-2.75%
-12.00
-46.84%
-8.17
-3693.55%
-0.22
Net Income From Continuing Operations
-26.28
-91.41%
-13.73
+77.30%
-60.48
-1471.89%
4.41
Depreciation Amortization Depletion
0.51
+26.17%
0.40
+6.67%
0.38
+63.92%
0.23
Depreciation
0.51
+26.17%
0.40
+6.67%
0.38
+63.92%
0.23
Depreciation And Amortization
0.51
+26.17%
0.40
+6.67%
0.38
+63.92%
0.23
Other Non Cash Items
—
-39.49
-176.48%
51.63
+520.76%
8.32
Stock Based Compensation
16.22
-60.20%
40.76
0.00
-100.00%
4.58
Asset Impairment Charge
—
—
0.25
—
Operating Gains Losses
-0.06
-204.33%
0.06
+167.49%
0.02
+105.26%
-0.41
Gain Loss On Investment Securities
-0.06
-204.33%
0.06
+167.49%
0.02
+105.26%
-0.41
Unrealized Gain Loss On Investment Securities
—
—
-2.73
+44.74%
-4.95
Change In Working Capital
-2.72
-49553.76%
-0.01
-101.87%
0.29
-60.25%
0.74
Change In Receivables
—
—
-0.27
0.00
Change In Prepaid Assets
0.10
+141.40%
-0.25
+22.54%
-0.32
-171.11%
0.45
Change In Payables And Accrued Expense
-2.04
-302.97%
1.00
+96.74%
0.51
+75.36%
0.29
Change In Accrued Expense
-0.07
+89.11%
-0.68
-12.85%
-0.60
-206.18%
0.57
Change In Payable
-1.96
-216.52%
1.69
+51.28%
1.11
+282.80%
0.29
Change In Account Payable
-1.96
-216.52%
1.69
+51.28%
1.11
+551.31%
0.17
Change In Other Current Assets
-0.49
+4.10%
-0.51
-257.85%
0.32
+228.35%
-0.25
Change In Other Current Liabilities
-0.30
-17.91%
-0.25
-13.14%
-0.22
-95.30%
-0.11
Investing Cash Flow
-0.06
0.00
+100.00%
-0.13
0.00
Cash Flow From Continuing Investing Activities
-0.06
0.00
+100.00%
-0.13
0.00
Net PPE Purchase And Sale
-0.06
0.00
+100.00%
-0.13
+72.24%
-0.48
Purchase Of PPE
-0.06
0.00
+100.00%
-0.13
+72.24%
-0.48
Capital Expenditure
-0.06
—
-0.13
+72.24%
-0.48
Net Other Investing Changes
—
—
342.92
—
Financing Cash Flow
11.66
-4.64%
12.23
+215.82%
3.87
0.00
Cash Flow From Continuing Financing Activities
11.66
-4.64%
12.23
+215.82%
3.87
0.00
Net Issuance Payments Of Debt
3.40
+240.00%
1.00
-75.00%
4.00
0.00
Issuance Of Debt
3.40
+240.00%
1.00
-75.00%
4.00
0.00
Long Term Debt Issuance
3.40
+240.00%
1.00
-75.00%
4.00
0.00
Net Long Term Debt Issuance
3.40
+240.00%
1.00
-75.00%
4.00
0.00
Short Term Debt Issuance
—
—
1.32
0.00
Net Short Term Debt Issuance
—
—
1.32
0.00
Net Common Stock Issuance
4.86
0.00
+100.00%
-342.98
0.00
Common Stock Payments
—
—
-342.98
0.00
Repurchase Of Capital Stock
—
—
-342.98
0.00
Net Other Financing Charges
3.40
+1382.59%
0.23
+279.51%
-0.13
—
Changes In Cash
-0.73
-416.84%
0.23
+105.20%
-4.43
-1957.55%
-0.22
Beginning Cash Position
1.28
+21.91%
1.05
-80.81%
5.48
+1491.57%
0.34
End Cash Position
0.55
-56.95%
1.28
+21.91%
1.05
+714.64%
0.13
Free Cash Flow
-12.39
-3.29%
-12.00
-44.49%
-8.30
-3755.30%
-0.22
Common Stock Issuance
4.86
0.00
—
—
Issuance Of Capital Stock
4.86
-55.80%
11.00
0.00
—
Net Preferred Stock Issuance
0.00
-100.00%
11.00
0.00
—
Preferred Stock Issuance
0.00
-100.00%
11.00
0.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category